Reference - Detail
| RRC ID | 61226 |
|---|---|
| Author | Hikiji H, Ishii S, Shindou H, Takato T, Shimizu T. |
| Title | Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy. |
| Journal | J Clin Invest |
| Abstract |
While platelet-activating factor (PAF) is produced in various diseases associated with bone resorption, its functions in bone metabolism remain unknown. Using PAF receptor-deficient mice, we evaluated the role of PAF in the development of bone resorption following ovariectomy, a model of postmenopausal osteoporosis. Through observations of bone mineral density and histomorphometric parameters, it was found that bone resorption was markedly attenuated in PAF receptor-deficient mice, indicating that PAF links estrogen depletion and osteoporosis in vivo. Osteoclasts expressed higher amounts of the enzymes required for PAF biosynthesis than osteoblasts. TNF-alpha and IL-1beta increased the acetyl-coenzyme A:lyso-PAF acetyltransferase activity in osteoclasts. Osteoclasts, but not osteoblasts, expressed the functional PAF receptor. PAF receptor stimulation prolonged the survival of osteoclasts in vitro. Furthermore, osteoclasts treated with a PAF receptor antagonist, and also those from PAF receptor-deficient mice, showed reductions in survival rate and Ca resorption activity. Consistently, in organ cultures, bone resorption was significantly suppressed by a PAF receptor antagonist treatment or genetic PAF receptor deficiency. Thus, these results suggest that, through the inflammatory cytokines, estrogen depletion enhances PAF production as a unique autocrine factor for osteoclast functions. Inhibition of PAF function might pave the way for a new strategy to prevent postmenopausal bone loss without disturbing osteoblast functions. |
| Volume | 114(1) |
| Pages | 85-93 |
| Published | 2004-7-1 |
| DOI | 10.1172/JCI20504 |
| PMID | 15232615 |
| PMC | PMC437965 |
| MeSH | Animals Bone Resorption / prevention & control Disease Models, Animal Female Mice Mice, Knockout Osteoporosis / etiology Osteoporosis / prevention & control* Ovariectomy / adverse effects* Platelet Membrane Glycoproteins / deficiency* Platelet Membrane Glycoproteins / genetics Platelet Membrane Glycoproteins / physiology* Receptors, G-Protein-Coupled / deficiency* Receptors, G-Protein-Coupled / genetics Receptors, G-Protein-Coupled / physiology* |
| IF | 11.864 |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | Patent(IFI CLAIMS) |
| Total number of mentions | 2 |
| Altmetric score changes over past 6months | 0.0 |
| Resource | |
| Human and Animal Cells | MC3T3-E1(RCB1126) |